Open
Imvaria 是由 Stanford/Google-team 支持的軟體醫(yī)療科技公司，專注在開發(fā)透過(guò)人工智慧賦能的數(shù)位化生物標(biāo)記(Digital Biomarkers)，軟體結(jié)合醫(yī)療影像和實(shí)驗(yàn)室數(shù)據(jù)，將應(yīng)用在嚴(yán)重和罕見疾病。目前首要關(guān)注肺部、肝臟、腎臟和癌癥等領(lǐng)域，本團(tuán)隊(duì)期待可以利用數(shù)位化生物標(biāo)記提高嚴(yán)重疾病的早期診斷率。
IMVARIA's lead digital biomarker, Fibresolve, demonstrates the power of IMVARIA's innovation to serve as adjunct in assessment of interstitial lung disease (ILD) including idiopathic pulmonary fibrosis (IPF), potentially avoiding expensive, invasive surgical testing.* Fibresolve uses AI to analyze CT imaging for specific, novel patterns.
IMVARIA's lead digital biomarker, Fibresolve, demonstrates the power of IMVARIA's innovation to serve as adjunct in assessment of interstitial lung disease (ILD) including idiopathic pulmonary fibrosis (IPF), potentially avoiding expensive, invasive surgical testing.* Fibresolve uses AI to analyze CT imaging for specific, novel patterns.